식품 알레르기 진단 및 치료제 시장 : 제품 유형, 기술, 공급원, 성분, 최종 사용자별 - 세계 예측(2025-2030년)

The Food Allergy Diagnostics & Therapeutics Market was valued at USD 5.86 billion in 2023, expected to reach USD 6.43 billion in 2024, and is projected to grow at a CAGR of 10.35%, to USD 11.69 billion by 2030.

The food allergy diagnostics and therapeutics market primarily encompasses products and services aimed at identifying and managing food allergies, from diagnostic tests to therapeutic solutions. The necessity for these technologies arises from a growing prevalence of food allergies globally, impacting millions of lives and necessitating accurate diagnostics and effective treatments to enhance quality of life and reduce healthcare costs. Applications range from clinical settings, where in vitro and molecular allergen diagnostics are used, to at-home testing kits for individual consumer use. The end-use scope includes hospitals, clinics, and research institutions focused on allergy and immunology. Key growth influencers include rising awareness of food allergies, advancements in biotechnology, and increasing investments in research and development. The latest potential opportunities lie in the development of novel biologics, hypoallergenic food products, and personalized medicine approaches tailored to individual allergen profiles. Exploiting advancements in digital health for patient education and adherence to therapies also presents substantial growth avenues.

However, the market faces limitations such as high costs of advanced diagnostic tests, regulatory hurdles, and variability in food allergy manifestations that complicate standardization in diagnostics and treatment. Slow adoption in developing regions due to lack of awareness and infrastructure also poses significant challenges. To foster innovation, businesses can focus on developing cost-effective, non-invasive diagnostic technologies, enhancing food allergen labeling, and investing in AI and machine learning to predict allergy trends and treatment effectiveness. Additionally, collaboration with research institutions to explore gut microbiome therapies could offer promising insights. Despite its challenges, the market is dynamic, marked by significant research and development activities and a steady influx of innovative solutions. As the demand for more precise diagnosis and effective therapeutics grows, the industry is poised for expansion, with companies that leverage technology and strategic partnerships likely to gain a competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Food Allergy Diagnostics & Therapeutics Market

The Food Allergy Diagnostics & Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidences of allergic conditions among pediatric and adult populations
  • Increasing funds by organizations in food allergy diagnostics
  • Rising patient demand for in vitro diagnostic blood tests
• Market Restraints
  • Limited awareness and less implementation of food allergic testing methods
• Market Opportunities
  • Ongoing technological advancements in food allergy diagnostics and therapeutics
  • Increasing number of research and development initiatives for the development of drugs
• Market Challenges
  • Stringent regulatory framework for food allergy diagnostics and therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Food Allergy Diagnostics & Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Food Allergy Diagnostics & Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Food Allergy Diagnostics & Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Food Allergy Diagnostics & Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Food Allergy Diagnostics & Therapeutics Market

A detailed market share analysis in the Food Allergy Diagnostics & Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Food Allergy Diagnostics & Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Food Allergy Diagnostics & Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Food Allergy Diagnostics & Therapeutics Market

A strategic analysis of the Food Allergy Diagnostics & Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abello A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioMerieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestle Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Food Allergy Diagnostics & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Diagnostic Tests Type and Therapeutic Treatment Type. The Diagnostic Tests Type is further studied across In Vitro and In Vivo/Skin. The In Vivo/Skin is further studied across Patch Test and Skin Prick Test. The Therapeutic Treatment Type is further studied across Antihistamines and Epinephrine Auto-Injector.
• Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay and Polymerase Chain Reaction.
• Based on Source, market is studied across Eggs, Fish, Milk, Peanuts, Shellfish, Soy, Tree Nuts, and Wheat.
• Based on Component, market is studied across Consumables, Instruments, and Services.
• Based on End-User, market is studied across Academic Research Institutes, Diagnostics Laboratories, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of allergic conditions among pediatric and adult populations
    • 5.1.1.2. Increasing funds by organizations in food allergy diagnostics
    • 5.1.1.3. Rising patient demand for in vitro diagnostic blood tests
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and less implementation of food allergic testing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological advancements in food allergy diagnostics and therapeutics
    • 5.1.3.2. Increasing number of research and development initiatives for the development of drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory framework for food allergy diagnostics and therapeutics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Food Allergy Diagnostics & Therapeutics Market, by Product Type

• 6.1. Introduction
• 6.2. Diagnostic Tests Type
  • 6.2.1. In Vitro
  • 6.2.2. In Vivo/Skin
    • 6.2.2.1. Patch Test
    • 6.2.2.2. Skin Prick Test
• 6.3. Therapeutic Treatment Type
  • 6.3.1. Antihistamines
  • 6.3.2. Epinephrine Auto-Injector

7. Food Allergy Diagnostics & Therapeutics Market, by Technology

• 7.1. Introduction
• 7.2. Enzyme-Linked Immunosorbent Assay
• 7.3. Polymerase Chain Reaction

8. Food Allergy Diagnostics & Therapeutics Market, by Source

• 8.1. Introduction
• 8.2. Eggs
• 8.3. Fish
• 8.4. Milk
• 8.5. Peanuts
• 8.6. Shellfish
• 8.7. Soy
• 8.8. Tree Nuts
• 8.9. Wheat

9. Food Allergy Diagnostics & Therapeutics Market, by Component

• 9.1. Introduction
• 9.2. Consumables
• 9.3. Instruments
• 9.4. Services

10. Food Allergy Diagnostics & Therapeutics Market, by End-User

• 10.1. Introduction
• 10.2. Academic Research Institutes
• 10.3. Diagnostics Laboratories
• 10.4. Hospitals & Clinics

11. Americas Food Allergy Diagnostics & Therapeutics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Food Allergy Diagnostics & Therapeutics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Food Allergy Diagnostics & Therapeutics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Aleph Farms Increases Production Capabilities With VBL Therapeutics Facility Acquisition And ESCO Aster Partnership
  • 14.3.2. Jerath Path Labs expands the reach in India in allergy-testing
  • 14.3.3. Deeside firm secures US patent for food allergy diagnostics
  • 14.3.4. "Thermo Fisher's Wheat And Sesame Allergy Blood Tests Earn FDA Nod
  • 14.3.5. CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics' Investigational Peanut Allergy Treatment - CoreRx(R)
  • 14.3.6. Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
  • 14.3.7. Allergy Therapeutics Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate
  • 14.3.8. FDA approves IND application for peanut allergy drug candidate
  • 14.3.9. Praetura Ventures leads £2.9m investment in food allergy diagnostic company
  • 14.3.10. Ukko raises $40 million to address food allergies with AI
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 7 Drops Diagnostics, Inc.
• 2. ACON Laboratories, Inc.
• 3. AESKU.GROUP GmbH
• 4. ALK-Abello A/S
• 5. Allergy Therapeutics PLC
• 6. Alpha Laboratories
• 7. Apexhealth by Acecgt Diagnostic Limited
• 8. Apollo Diagnostics
• 9. Aster Clinical Lab LLP
• 10. Astra Biotech GmbH
• 11. bioMerieux SA
• 12. Cerascreen GmbH
• 13. Eurofins Scientific (Ireland) Limited
• 14. EUROIMMUN Medizinische Labordiagnostika AG
• 15. HollisterStier Allergy by Jubilant Pharma Holdings Inc.
• 16. HYCOR Biomedical
• 17. Indoor Biotechnologies, Inc.
• 18. Laboratory Corporation of America Holdings.
• 19. Lincoln Diagnostics, Inc.
• 20. Medeca Pharma AB
• 21. Microbac Laboratories, Inc.
• 22. Minaris Medical America, Inc.
• 23. Neogen Corporatio
• 24. Nestle Health Science
• 25. Omega Diagnostics Group PLC
• 26. Prota Therapeutics Pty. Ltd.
• 27. Quest Consumer Inc.
• 28. R-Biopharm AG
• 29. Romer Labs Division Holding GmbH
• 30. ROXALL Medizin GmbH
• 31. Siemens AG
• 32. STALLERGENES GREER International AG
• 33. Tecan Trading AG
• 34. Thermo Fisher Scientific Inc.